Alliances
The collaboration will focus on the development of three of Genmab’s bispecific antibodies and will also involve a discovery research collaboration for future antibody therapeutics for cancer.
Michael Yu, chairman and chief executive officer of Innovent Biologics, said the deal with Roche will help the company continue to move forward in the cellular therapy space.
Alphamab Oncology, based in Suzhou, China, inked a collaboration deal with Sanofi (China) Investment Co. to advance clinical trials of Alphamab’s KN026 with Sanofi’s Taxotere (docetaxel) in HER2+ breast cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
Daiichi Sankyo announced on May 28 that it had entered an agreement with Syneos Health to form a coalition dedicated to bringing new cancer therapies to patients in a safe and effective manner.
Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins for the treatment of cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 4, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 3, 2020.
Emergent BioSolutions, a contract development and manufacturing organization, announced it had signed a public-private partnership under Operation Warp Speed worth about $628 million.
PRESS RELEASES